EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Short-Term Efficacy and Safety of Scleral Lenses in the Management of Severe Dry Eye in a Chinese Population

Chuwei Lu iD, Danjie Han, Li Zeng, Jiaxu Hong, Daddi Fadel, Xingtao Zhou, Zhi Chen, Qihua Le iD

Journal of Clinical Medicine · 21.01.2025 · 14 (3) · 658

DOI: 10.3390/jcm14030658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.01.2025. Verfasst von Chuwei Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Eye, Ear, Nose & Throat Hospital of Fudan University, Shanghai 200031, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Discipline Program of Sixth Round of the Three-year Public Health Action Plan (Year 2023-2025) of Shanghai, China, Shanghai Commission of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Scleral lenses (SLs) are recommended in DEWS II to treat dry eye (DE) patients that do not respond well to conventional therapies. This study aimed to evaluate the short-term (one month) efficacy and safety of SLs in the management of severe DE.

Methods

This single-center prospective study enrolled 15 patients (22 eyes) who were diagnosed with severe DE. The Ocular Surface Disease Index (OSDI), the Chinese version of the 25-item National Eye Institute Visual Function Questionnaire (CHI-VFQ-25), and LogMAR best-corrected visual acuity (BCVA) were evaluated at baseline and one month following SL fitting. DE-related parameters were obtained and analyzed before and after one month of SL treatment, including tear-film breakup time (TBUT), corneal fluorescein staining (CFS), non-invasive breakup time (NIBUT), tear meniscus height (TMH), Schirmer I test (SIT), and meibomian gland (MG) dropout. Complications and adverse events were monitored.

Results

OSDI scores (53.9 ± 28.1 vs. 10.4 (4.2–25), p = 0.0001) and CFS scores (10.2 ± 3.9 vs. 7 (0–12), p = 0.001) decreased after one month of SL therapy, while CHI-VFQ-25 scores (74.4 (54.8–83.8) vs. 95 (78.7–98), p = 0.0001) and TBUT (0.6 ± 0.5 vs. 2.2 ± 1.0, p < 0.0001) increased significantly. LogMAR BCVA improved from 0 (0–0.1) to 0 (0–0) (p = 0.0147). The average types of medications per eye decreased from 2.82 ± 1.01 to 1.32 ± 0.64 (p = 0.025), and the proportion of eyes using glucocorticoids significantly decreased from 63.6% to 13.6% (p = 0.001). No severe SL-related adverse events were reported.

Conclusions

SL treatment quickly alleviated subjective symptoms as well as clinical signs of DE with good safety and enhanced the visual function and vision-related quality of life, showing its usefulness in the management of severe DE.

Schlagwörter

Stichwörter der Autor:innen

dry eyeefficacysafetyscleral lensesvision-related quality of life

Autor:innen und Institutionen

  • Department of Ophthalmology, Eye, Ear, Nose & Throat Hospital of Fudan University, Shanghai 200031, China.
  • NHC Key laboratory of Myopia and Related Eye Diseases, Shanghai 200031, China.
  • Shanghai Engineering Research Center of Synthetic Immunology, Shanghai 200032, China.
  • Department of Ophthalmology, Children's Hospital of Fudan University, National Pediatric Medical Center of China, Shanghai 201102, China.
  • Centre for Ocular Research & Education, School of Optometry & Vision Science, University of Waterloo, Waterloo, ON N2L 3G1, Canada.

ORCID-Profile: Chuwei Lu, Qihua Le

Förderung

  • National Natural Science Foundation of China
  • Key Discipline Program of Sixth Round of the Three-year Public Health Action Plan (Year 2023-2025) of Shanghai, China
  • Shanghai Commission of Science and Technology
  • Natural Science Foundation of Shanghai
  • Key Discipline Program of the Sixth Round of the Three-Year Public Health Action Plan (Year 2023–2025) of Shanghai, China

Zitieren

APA

Lu, C., Han, D., Zeng, L., Hong, J., Fadel, D., Zhou, X., Chen, Z., & Le, Q. (2025). Short-Term Efficacy and Safety of Scleral Lenses in the Management of Severe Dry Eye in a Chinese Population. Journal of Clinical Medicine, 14(3), 658. https://doi.org/10.3390/jcm14030658

Vancouver

Lu C, Han D, Zeng L, Hong J, Fadel D, Zhou X, et al. Short-Term Efficacy and Safety of Scleral Lenses in the Management of Severe Dry Eye in a Chinese Population. Journal of Clinical Medicine. 2025;14(3):658. doi:10.3390/jcm14030658

BibTeX
@article{Lu2025,
  author = {Lu, Chuwei and Han, Danjie and Zeng, Li and Hong, Jiaxu and Fadel, Daddi and Zhou, Xingtao and Chen, Zhi and Le, Qihua},
  title = {Short-Term Efficacy and Safety of Scleral Lenses in the Management of Severe Dry Eye in a Chinese Population},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {3},
  pages = {658},
  doi = {10.3390/jcm14030658}
}
Kostenlos starten →